Catalyst Pharmaceutical Partners Inc (NASDAQ:CPRX)

During the Trading Day
2.55 +0.10 / +4.08%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.50 -0.05 / -1.96%
Volume: 300.00
Health Technology
Pharmaceuticals: Other

Company Description

Catalyst Pharmaceutical Partners, Inc. is a development-stage specialty pharmaceutical company, which focuses on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. The company has two products in development, and is currently evaluating its lead product GABA aminotransferase inhibitor candidate, CPP-109 (vigabatrin) for the treatment of cocaine addiction and it also expects to evaluate CPP-109 for the treatment of other addictions. It also develops CPP-115, another GABA aminotransferase inhibitor that is more potent than vigabatrin and has reduced side effects from those associated with vigabatrin. Catalyst Pharmaceutical Partners was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceutical Partners, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 529-2522
Investor Relations:



Individual stakeholders20.37%
Other institutional19.58%
Mutual fund holders14.00%

Top Executives

Patrick J. McEnanyChairman, President & Chief Executive Officer
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeChief Financial Officer, Treasurer & VP
Charles W. GorodetzkyChief Medical Officer
M. Douglas WinshipVice President-Regulatory Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.